These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 34476647
1. Juvenile Behçet's disease: a tertiary center experience. Ekici Tekin Z, Çelikel E, Aydin F, Kurt T, Sezer M, Tekgöz N, Karagöl C, Coşkun S, Kaplan MM, Çelikel Acar B. Clin Rheumatol; 2022 Jan; 41(1):187-194. PubMed ID: 34476647 [Abstract] [Full Text] [Related]
2. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan. Hu YC, Yang YH, Lin YT, Wang LC, Yu HH, Lee JH, Chiang BL. BMC Pediatr; 2019 Jul 11; 19(1):232. PubMed ID: 31296171 [Abstract] [Full Text] [Related]
3. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis. Klaeger AJ, Tran VT, Hiroz CA, Morisod L, Herbort CP. Int Ophthalmol; 2004 Jan 11; 25(1):57-63. PubMed ID: 15085978 [Abstract] [Full Text] [Related]
4. Paediatric Behçet's disease: a UK tertiary centre experience. Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA. Clin Rheumatol; 2016 Oct 11; 35(10):2509-16. PubMed ID: 26833394 [Abstract] [Full Text] [Related]
5. Systemic involvements and preferred treatments in a large cohort of Behçet's disease. Yilmaz S, Karadag O, Yazisiz V, Altun B, Gezer M, Karaman M, Cinar M, Erdem H, Pay S, Dinc A. Rheumatol Int; 2013 Dec 11; 33(12):3025-30. PubMed ID: 23881265 [Abstract] [Full Text] [Related]
6. Clinical profiling, treatment characteristics and outcome in Behcet's Disease (BD)-A retrospective cohort study from Karnataka Rheumatology Association (KRA). Rao VK, Kodali RS, Patil A, Chebbi P, Subramanian R, Kumar S, Singh YP, Chandrashekara S, Shobha V. Clin Rheumatol; 2024 Oct 11; 43(10):3223-3230. PubMed ID: 39096360 [Abstract] [Full Text] [Related]
7. Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros). Liozon E, Roussin C, Puéchal X, Garou A, Valadier P, Périnet I, Raffray L, Théry Y, De Lagarde B. Joint Bone Spine; 2011 Mar 11; 78(2):166-70. PubMed ID: 20599413 [Abstract] [Full Text] [Related]
8. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience. Bergamo S, di Meo N, Stinco G, Bonin S, Trevisini S, Trevisan G. Acta Dermatovenerol Croat; 2017 Dec 11; 25(4):295-297. PubMed ID: 30064603 [Abstract] [Full Text] [Related]
9. Clinical features of chinese patients with Behçet's disease. Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A. Ophthalmology; 2008 Feb 11; 115(2):312-318.e4. PubMed ID: 17692378 [Abstract] [Full Text] [Related]
10. Spectrum of Behçet's disease in the Indian population. Sachdev N, Kapali N, Singh R, Gupta V, Gupta A. Int Ophthalmol; 2009 Dec 11; 29(6):495-501. PubMed ID: 18936879 [Abstract] [Full Text] [Related]
11. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey. Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, Mizuki N. Mod Rheumatol; 2020 Jul 11; 30(4):708-714. PubMed ID: 31386589 [Abstract] [Full Text] [Related]
12. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry. Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R. Pediatr Rheumatol Online J; 2017 Dec 21; 15(1):84. PubMed ID: 29268757 [Abstract] [Full Text] [Related]
13. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia. Houman MH, Bellakhal S, Ben Salem T, Hamzaoui A, Braham A, Lamloum M, Monia SK, Ben Ghorbel I. Clin Neurol Neurosurg; 2013 Oct 21; 115(10):2015-8. PubMed ID: 23830180 [Abstract] [Full Text] [Related]
14. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis]. Zlatanović G, Jovanović S, Veselinović D, Zivković M. Vojnosanit Pregl; 2012 Feb 21; 69(2):168-74. PubMed ID: 22500372 [Abstract] [Full Text] [Related]
15. Neuro-Behçet's Disease Onset in the Context of Tuberculous Meningoencephalitis: A Case Report. Antonescu F, Butnariu I, Antonescu-Ghelmez D, Tuta S, Voinescu BA, Manea MC, Bucur AI, Chelmambet AS, Moraru A. Medicina (Kaunas); 2023 Dec 13; 59(12):. PubMed ID: 38138266 [Abstract] [Full Text] [Related]
16. Disease activity and outcomes in juvenile Behçet's disease: 10 years' experience of a single centre. Gezgin Yıldırım D, Bakkaloğlu SA, Hasanreisoglu M, Buyan N. Clin Exp Rheumatol; 2020 Dec 13; 38 Suppl 127(5):105-111. PubMed ID: 33253097 [Abstract] [Full Text] [Related]
17. Single center study on ethnic and clinical features of Behcet's disease in Moscow, Russia. Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, Takeno M, Ishigatsubo Y, Mizuki N, Nasonov E, Ishida S, Ohno S. Clin Rheumatol; 2015 Feb 13; 34(2):321-7. PubMed ID: 24322831 [Abstract] [Full Text] [Related]
18. HLA-B51 Impact on Clinical Symptoms in Behcet's Disease. Pamukcu M, Duran TI, Demirag MD. J Coll Physicians Surg Pak; 2022 Jul 13; 32(7):904-908. PubMed ID: 35795941 [Abstract] [Full Text] [Related]
19. Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience. Yalcin Kehribar D, Gunaydin S, Ozgen M. Int J Rheum Dis; 2021 Oct 13; 24(10):1302-1307. PubMed ID: 34427044 [Abstract] [Full Text] [Related]
20. A study of familial occurrence of Behçet's disease with and without ocular lesions. Nishiyama M, Nakae K, Umehara T. Jpn J Ophthalmol; 2001 Oct 13; 45(3):313-6. PubMed ID: 11369384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]